A combination of positive tumor HLA-I and negative PD-L1 expression provides an immune rejection mechanism in bladder cancer

Authors :: Federico Garrido
J. Moreno Jiménez
Francisco Perea
M. Villamediana Abad
F. Javier Carretero
José Manuel Cózar-Olmo
C.I. Ramos Alaminos
Manuela Expósito-Ruiz
M.C. Salas Moreno
Tomás R. Rodríguez
J. Flores Martín
Francisco Ruiz-Cabello
Natalia Aptsiauri
Source :: European Urology Open Science, Vol 19, Iss, Pp e1428-(2020)
Publication Year :: 2020
Publisher :: Elsevier, 2020.

Subjects :: Bladder cancer
Mechanism (biology)
business.industry
Urology
medicine.disease
lcsh:Diseases of the genitourinary system. Urology
lcsh:RC870-923
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
lcsh:RC254-282
medicine
Cancer research
Pd l1 expression
business
Immune rejection

Tools